Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3266
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07257055 | Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study | ||
| NCT01560949 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | ||
| NCT06843720 | Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems | ||
| NCT02228525 | Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes | ||
| NCT00749840 | Attitudes and Beliefs and the Steps of HIV Care | ||
| NCT00891618 | Acupuncture for Chemo-Induced Peripheral Neuropathy | ||
| NCT02481297 | Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients | ||
| NCT06967610 | Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). | ||
| NCT02469779 | Middle and High School Students' Reactions to a Health Interactive Website: ASPIRE Reactions | ||
| NCT06065462 | Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100 | ||
| NCT00102635 | 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC) | ||
| NCT07220096 | Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes | ||
| NCT03144778 | Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer | ||
| NCT03523689 | Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral Bronchoscopy | ||
| NCT01949662 | Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer | ||
| NCT00004246 | Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx | ||
| NCT02719015 | Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma | ||
| NCT01439659 | Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer | ||
| NCT02823847 | Non Invasive Oral Cancer Screening Among HIV Infected Individuals | ||
| NCT04776876 | Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome | ||
| NCT04513990 | Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) | ||
| NCT00307710 | Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma | ||
| NCT04957615 | Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression | ||
| NCT01372540 | Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | ||
| NCT00002835 | Combination Chemotherapy in Treating Patients With Lymphoma | ||
| NCT04589624 | An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy | ||
| NCT03207555 | Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) | ||
| NCT03950635 | Dietary Intervention in Patients with a History of Melanoma | ||
| NCT02483858 | Study of Oral PQR309 in Patients With Advanced Solid Tumors | ||
| NCT00810576 | Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma | ||
| NCT05041140 | Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment | ||
| NCT01787474 | Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT01217060 | Trimodality Management of T1b Esophageal Cancers | ||
| NCT04644224 | Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American Families | ||
| NCT05546827 | Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma | ||
| NCT00963859 | Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder | ||
| NCT05961696 | A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia | ||
| NCT01433029 | Objective Assessment of Technical Skills in Cardiothoracic Surgery | ||
| NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | ||
| NCT02392039 | Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma | ||
| NCT05100095 | Hypofractionated Radiation Therapy for Merkel Cell Carcinoma | ||
| NCT02138929 | LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma | ||
| NCT07218939 | Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures | ||
| NCT01681875 | Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes | ||
| NCT06259253 | Understanding Patient Experience Among Asians at MD Anderson | ||
| NCT05062395 | Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis | ||
| NCT02250937 | Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | ||
| NCT00317772 | Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | ||
| NCT01222195 | Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS) | ||
| NCT05501054 | Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma. |
